FindTrial
Sign In

Effect of body mass index on ED50 andED95 of intrathecal ropivacaine in pregnant patients undergoing cesarean delivery

Effect of body mass index on ED50 andED95 of intrathecal ropivacaine in pregnant patients undergoing cesarean delivery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCH-13003109
Enrollment
Unknown
Registered
2013-03-20
Start date
2013-03-29
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnant patients undergoing cesarean delivery

Interventions

Low BMI group (BMI less than 25):intrathecal ropivacaine
middle BMI group (BMI 25 to 30):intrathecal ropivacaine
High BMI group (BMI more than 30):intrathecal ropivacaine

Sponsors

Guangzhou Women andChildren Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: ASAI,II; singleton pregnancy; aged between 18 and 40 yr; gestational age of more than 37 completedweeks undergoing elective cesarean delivery; Less than two previous cesarean deliveries

Exclusion criteria

Exclusion criteria: significant medical or obstetric morbidityplacenta previa, andcongenital anomaly excluded if they have cardiorespiratory, renal or hepatic dysfunction. If they receive medications known to affect anesthetic requirements or allergy.

Design outcomes

Primary

MeasureTime frame
ED50 and ED95 of intrathecal ropivacain;—

Secondary

MeasureTime frame
the rate of hypotension;—

Countries

China

Contacts

Public ContactSong Xing Rong
songxr1966@sohu.com+86 13922416303

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026